Taysha (TSHA) insider files Form 144 to sell 54,491 vested RSUs

Rhea-AI Filing Summary

Taysha Gene Therapies (TSHA) filed a Form 144 reporting a proposed sale of 54,491 shares of common stock (RSU award) on 08/21/2025. The shares were a vested RSU grant settled in stock to the reporting person as consideration for continued employment. The broker listed is Maxim Group LLC and the sale is planned on Nasdaq. The filing shows an aggregate market value of $156,389.17 based on the proposed sale and lists 272,794,885 shares outstanding. The filer reports no other sales in the past three months.

Insights

Securities Analyst

TL;DR: Routine insider sale of vested RSUs; size is immaterial relative to outstanding shares.

The filing documents a scheduled resale of 54,491 vested RSUs through a broker on Nasdaq with an aggregate market value of $156,389.17. Compared with the 272.8 million shares outstanding, the proposed sale represents a de minimis percentage of the float, suggesting limited direct market impact. The absence of other sales in the prior three months and the stated origin as compensation for continued service indicate this is a compensatory distribution rather than a triggered liquidity event.

Corporate Governance Expert

TL;DR: Administrative disclosure of insider's vested compensation sale; governance disclosure requirements met.

The Form 144 provides required notice for an insider intending to sell shares derived from an RSU settlement. The filer affirms lack of undisclosed material adverse information and notes the transaction arose from employment compensation. This satisfies Rule 144 notice obligations and the filing contains no indications of governance disputes or unusual dilution beyond normal equity compensation practices.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group LLC 300 Park Avenue, 16th Floor New York NY 10022	54491	156389.17	272794885	08/21/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/21/2025	RSU Award	Issuer			54491	08/21/2025	Vested grant settled instock; consideration was Reporting Person's continued service as an employee ofthe Issuer.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TSHA Form 144 report?

The Form 144 reports a proposed sale of 54,491 common shares by a reporting person, planned for 08/21/2025, through Maxim Group LLC on Nasdaq.

Why were the TSHA shares being sold?

The shares originated from a vested RSU award settled in stock; the filing states the consideration was the reporting person's continued service as an employee.

What is the aggregate value and how large is the sale relative to TSHA outstanding shares?

Aggregate market value is reported as $156,389.17. The company has 272,794,885 shares outstanding, so the sale is a very small fraction of outstanding shares.

Were there any other sales by this person in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 indicate undisclosed material information about TSHA?

By signing, the reporting person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.